Bunge earnings beat by $0.14, revenue topped estimates

Bunge (NYSE: BG) reported Q3 EPS of $2.56, beating estimates by $0.14, with revenue at $23.8B, exceeding expectations. The company forecasted FY 2026 EPS of $9.25-$9.75, below the consensus of $9.51. Shares closed at $100.80, down 5.11% over 3 months but up 5.95% year-over-year.

Original reporting
Published Oct 29, 2026, 10:11 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 10:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BG
Bullish
medium confidence
Mentioned
$BG
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BGBullishMed
01

Why it matters

Traders can update near-term positioning based on the EPS and revenue beat, then reassess forward expectations using the FY 2026 EPS guidance versus consensus.

02

Market read

The combination of an EPS and revenue beat with FY 2026 guidance below consensus creates a two-sided catalyst for BG positioning.

03

What to watch

The article does not break out segment drivers, margin trends, or working-capital impacts, which are often the key determinants of whether the beat is durable.

Relevance 9/10Novelty 8/10Timing: post-earnings, same-day decision around the Q3 print and FY 2026 guidance

Background

This is a first-report style earnings update for Bunge’s Q3 results, including a full-year EPS guidance range.

Company-level read

Ticker impact

$BGBullishMedium confidence
Context

Bunge reported Q3 EPS of $2.56, beating the $2.42 estimate, and revenue of $23.8B versus $23.2B consensus, plus FY 2026 EPS guidance of $9.25-$9.75.

Expected impact

Shares may face near-term support from the earnings beat, but upside could be capped as guidance implies EPS below consensus.

Evidence & confidence

The article provides a clear beat versus consensus and a specific FY guidance range that is below the stated consensus, which typically offsets some of the positive surprise.

Market effects

As a major agribusiness/commodities-linked processor and trader, Bunge results can influence sentiment around margins and demand visibility in food/ag supply chains.

Primarily US-listed sentiment; limited direct regional spillover beyond commodity-linked equities.

Global agri-commodity and processing demand expectations may be marginally repriced based on Bunge’s guidance tone.

Counterpoint

The guidance range being below consensus could signal margin pressure or cost headwinds, so the beat may not translate into sustained earnings momentum.

Key entities

  • Bunge

    NYSE-listed agribusiness company reporting Q3 EPS and revenue, and issuing FY 2026 EPS guidance.

Related articles

$BGMed

What Bunge Global (BG) Said on Its Q3 Earnings Call

Bunge Global (BG) reported Q3 earnings with mixed results. Grain merchandising gains were offset by weaker ocean freight and milling results. CEO Greg Heckman highlighted integration progress with Viterra, expecting $200M in cost savings by 2026. The company anticipates $0.50 per share from synergies in 2027. Bunge generated $2B in adjusted funds from operations, with $1.6B in discretionary cash flow.

$BGHighAI 9/10

Bunge (BG) Q3 2026 Earnings Call Transcript

Bunge (BG) reported Q3 2026 EPS of $1.64, up from $0.86 in 2025. Adjusted EPS was $2.56, with adjusted EBIT at $997M. The company maintained its full-year adjusted EPS guidance of $9.25-$9.75. Bunge highlighted progress from its Viterra combination, including cost savings and new projects. It also announced the sale of non-core sugar mills in Brazil. The company's liquidity position remains strong, with $9.7B in credit facilities.

$BGMedAI 8/10

Bunge Global 3Q 2026: Revenue $23.8B, Net income $318M, EPS $1.64— 10-Q Summary

Bunge Global reported Q3 2026 revenue of $23.8B, net income of $318M, and EPS of $1.64, up from $22.16B, $166M, and $0.84 respectively in the prior-year quarter. Nine-month net sales rose 50% to $69.7B, driven by Viterra and higher commodity prices. Soybean and softseed segment EBIT increased significantly, while sugarcane mill sale charges and Ukraine-related inventory damage weighed on results.

$BGHighAI 8/10

Bunge Q3 2026 slides: earnings beat offset by rising costs

Bunge (BG) reported Q3 2026 adjusted EPS of $2.56, beating estimates but shares fell slightly due to higher costs. The company maintained full-year guidance and highlighted benefits from Viterra integration. Adjusted segment EBIT rose 7.9% YoY, with strong performance in soybean and softseed processing, but declines in tropical oils and grain merchandising.

$BGMedAI 8/10

Bunge Q3 2026: Net Income $318 Million, Adjusted EPS $2.56

Bunge reported Q3 2026 net income of $318M, up from $166M YoY. Adjusted EPS was $2.56, and revenue reached $23.8B. The company maintained its full-year adjusted EPS outlook of $9.25-$9.75. Soybean processing improved, while Tropical Oils faced geopolitical disruptions. Bunge also announced the sale of two Brazilian sugarcane mills and progress on Viterra synergies.